Increased ROS levels are documented in the adipose tissue of obese, insulin-resistant mice and humans, and are important triggers for inflammation and insulin resistance, being also able to negatively affect adiponectin release [43,44]. This evidence concerns the gene ADIPOQ and Insulin resistance.